Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Sales | 23,575 | 21,624 | 20,132 | 31,743 | 23,631 |
| Gross Profit | 23,575 | 21,624 | 20,132 | 31,743 | 23,631 |
| Operating Expenses | 57,302 | 55,471 | 49,832 | 44,042 | 43,414 |
| Operating Income | -33,727 | -33,847 | -29,700 | -12,299 | -19,783 |
| Other Income | 333 | 439 | 545 | 677 | 1,149 |
| Pre-tax Income | -33,394 | -33,408 | -29,155 | -11,622 | -18,634 |
| Income Tax | -8,795 | -9,384 | -7,110 | -3,294 | 10,707 |
| Net Income Continuous | -24,599 | -24,024 | -22,045 | -8,328 | -29,341 |
| Net Income | $-24,599 | $-24,024 | $-22,045 | $-8,328 | $-29,341 |
| EPS Basic Total Ops | -1.23 | -1.19 | -1.09 | -0.41 | -1.48 |
| EPS Basic Continuous Ops | -1.22 | -1.19 | -1.09 | -0.41 | -1.48 |
| EPS Diluted Total Ops | -1.23 | -1.19 | -1.09 | -0.41 | -1.45 |
| EPS Diluted Continuous Ops | -1.22 | -1.19 | -1.09 | -0.41 | -1.45 |
| EBITDA(a) | $-32,321 | $-32,464 | $-28,341 | $-10,997 | $-18,475 |